Next Article in Journal
Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community
Next Article in Special Issue
Complex Contact Network of Patients at the Beginning of an Epidemic Outbreak: An Analysis Based on 1218 COVID-19 Cases in China
Previous Article in Journal
Alcohol Use in China: Unrecorded and Recorded Bai Jiu in Three Rural Regions
Previous Article in Special Issue
The Effects of a Five-Month Lockdown Due to COVID-19 on Physical Fitness Parameters in Adolescent Students: A Comparison between Cohorts
Article

Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey

1
Department of Allergology and Pulmonology, Medical University of Gdansk, 80-211 Gdansk, Poland
2
Department of Rehabilitation Medicine, Faculty of Health Sciences with Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland
3
Department of Internal and Pediatric Nursing, Faculty of Health Sciences with Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland
4
Department of Clinical Nutrition, Medical University of Gdansk, 80-211 Gdansk, Poland
*
Author to whom correspondence should be addressed.
Academic Editor: Paul B. Tchounwou
Int. J. Environ. Res. Public Health 2022, 19(1), 406; https://doi.org/10.3390/ijerph19010406
Received: 1 December 2021 / Revised: 23 December 2021 / Accepted: 29 December 2021 / Published: 30 December 2021
(This article belongs to the Collection Outbreak of a Novel Coronavirus: A Global Health Threat)
Background: Patients with Duchenne muscular dystrophy (DMD) may be at higher risk of a severe course of COVID-19. The aim of the study was to evaluate: (1) the incidence and course of COVID-19 infection in DMD patients; (2) the vaccination status of DMD patients; and (3) COVID-19 related anxiety among DMD families. Materials and Methods: The study was conducted during an online symposium for DMD patients and their families. All participants (DMD families; n = 150) were asked to fill in the online survey with questions about COVID-19 infection history, vaccination against SARS-CoV-2 and anxiety during pandemic. Results: 53 DMD patients filled in the survey. Five (9.43%) were COVID-19 positive with mild symptoms of respiratory infection and anosmia; 23 (42.6%) were vaccinated, but in almost 20% of DMD families, none of the family members was vaccinated. Respondents revealed anxiety related both to the vaccination procedure and to COVID-19 infection (complications after infection 93.6%, death 62.4% respondents). Changes in health care system organization also aroused concern among participants (85.3%). Conclusion: The course of the COVID-19 infection in DMD patients was mild. Not enough patients with DMD and their families are vaccinated. Education about the management of COVID-19 infections and the vaccination procedure for DMD patients is needed and expected. View Full-Text
Keywords: COVID-19; SARS-CoV-2 virus; Duchenne muscular dystrophy; neuromuscular disease; rare diseases; vaccination against SARS-CoV-2; vaccination against COVID-19; anxiety; COVID-19 pandemic COVID-19; SARS-CoV-2 virus; Duchenne muscular dystrophy; neuromuscular disease; rare diseases; vaccination against SARS-CoV-2; vaccination against COVID-19; anxiety; COVID-19 pandemic
MDPI and ACS Style

Wasilewska, E.; Sobierajska-Rek, A.; Śledzińska, K.; Małgorzewicz, S.; Jassem, E.; Wierzba, J. Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey. Int. J. Environ. Res. Public Health 2022, 19, 406. https://doi.org/10.3390/ijerph19010406

AMA Style

Wasilewska E, Sobierajska-Rek A, Śledzińska K, Małgorzewicz S, Jassem E, Wierzba J. Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey. International Journal of Environmental Research and Public Health. 2022; 19(1):406. https://doi.org/10.3390/ijerph19010406

Chicago/Turabian Style

Wasilewska, Eliza, Agnieszka Sobierajska-Rek, Karolina Śledzińska, Sylwia Małgorzewicz, Ewa Jassem, and Jolanta Wierzba. 2022. "Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey" International Journal of Environmental Research and Public Health 19, no. 1: 406. https://doi.org/10.3390/ijerph19010406

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop